immunity News and Research

RSS

New discovery could lead to the creation of a pan-coronaviruses vaccine

Next generation vaccines for Covid-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, concludes new research carried out by UCL scientists.

10 Nov 2021

Emergence of SARS-CoV-2 immune escape variants in an immunocompromised patient

A German case study recently published in the journal Nature Communications has characterized a long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection dynamics in an immunosuppressed kidney transplant recipient and provided evidence for the evolution of SARS-CoV-2 into potentially harmful immune escape mutants during persistent infections.

10 Nov 2021

Global progress toward measles elimination continues to decline amidst the pandemic

While reported measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a new report from the World Health Organization and U.S. Centers for Disease Control and Prevention.

10 Nov 2021

The immune response elicited by an inactivated SAR-CoV-2 vaccine

A team of researchers assessed antibody responses to the inactivated SARS-CoV-2 vaccine among vaccine recipients in Shenzhen, China.

10 Nov 2021

How effective are mask-wearing and social distancing in UK universities?

A new paper describes the effects of various non-pharmaceutical interventions in dealing with the spread of this virus among students, faculty, and staff on university campuses following the reopening of these institutions.

10 Nov 2021

Mechanism of SARS-CoV-2 antibody transfer into breastmilk

A recent study aimed to understand better the mechanism of antibody transfer to breastmilk in the setting of SARS-CoV-2 infection.

10 Nov 2021

How one health center is leading Chicago on kid covid shots

As the medical assistant put on rubber gloves and readied the syringe, 5-year-old Victoria Macias, wearing a pink Minnie Mouse mask and white blouse, turned her head away and closed her eyes.

10 Nov 2021

Finnish study highlights the need for mRNA COVID vaccine booster shots

A register-based cohort study of the effectiveness of COVID-19 vaccines was performed to help decision-making on providing booster doses to social and healthcare workers (HCWs) like nurses, physicians, dentists, and other professionals in Finland. In addition, it estimated the vaccine effectiveness after the second dose. This study is published on the medRxiv* preprint server.

9 Nov 2021

COVID-19 vaccination strategies that minimize R0 may offer greater protection to vulnerable age groups

In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.

9 Nov 2021

A measles-vectored COVID-19 vaccine induces strong immunity in animal model

A new study explores the potential of MV-based vaccines targeting the S protein of SARS-CoV-2.

9 Nov 2021

Psychiatric drug prevents some of the most serious complications of COVID-19, study finds

Leonard Imbula of the Healthy Mind Lab at Washington University School of Medicine in St. Louis holds a bottle of fluvoxamine, a psychiatric drug that has been shown, in a pair of studies conducted on two continents, to be an effective treatment for people sick with COVID-19.

9 Nov 2021

The role of T follicular helper cells in the humoral immune response to SARS-CoV-2

The current analysis indicates that cTfh cells react to the spike antigen following vaccination are associated with anti-S protein neutralizing antibodies.

9 Nov 2021

Pregnant women’s humoral response is dependent on SARS-CoV-2 strain

The current study from Israel discusses the change in antibody response with the trimester of infection and the infecting variant.

9 Nov 2021

Impact of COVID-19 pandemic on women’s experience of pregnancy in UK

The current study deals with the results of a study carried out on pregnant women.

9 Nov 2021

Novel tetravalent antibodies for the ultrapotent and broad neutralization of SARS-CoV-2 variants

Researchers from the University of Toronto set out to create a new tetravalent antibody that could bind with enough potency that it could remain effective against VOCs.

9 Nov 2021

Enhanced neutralizing antibody and T-cell responses by DNA-based vaccine encoding SARS-CoV-2 spike protein

Researchers from VaxiGen have been investigating the potential for a DNA vaccine boost to VP vaccines against coronavirus disease 2019.

9 Nov 2021

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections

Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in the real world to be highly efficacious in preventing infection, symptoms, hospitalizations, severe disease, and death related to coronavirus disease (COVID-19).

9 Nov 2021

Increase in SARS-CoV-2 seroprevalence in Irish HCWs during third wave of pandemic

Healthcare workers and people they live with are at an increased risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Hospital healthcare workers (HCWs) worldwide have been found to have a higher number of SARS-CoV-2 infections and higher antibody seroprevalence compared to the general population.

8 Nov 2021

Household transmission of SARS-CoV-2 delta variant in England

Researchers from Public Health England have been investigating how one of the most dangerous variants, the Delta variant, spreads within households in England.

8 Nov 2021

What are the anti-COVID drugs currently in development?

The first antiviral drugs effective against COVID-19 were recently approved in the UK and USA. A researcher from the Laboratory of Gene Technology has been exploring what we know so far.

8 Nov 2021

immunity News and Research

New discovery could lead to the creation of a pan-coronaviruses vaccine

Emergence of SARS-CoV-2 immune escape variants in an immunocompromised patient

Global progress toward measles elimination continues to decline amidst the pandemic

The immune response elicited by an inactivated SAR-CoV-2 vaccine

How effective are mask-wearing and social distancing in UK universities?

Mechanism of SARS-CoV-2 antibody transfer into breastmilk

How one health center is leading Chicago on kid covid shots

Finnish study highlights the need for mRNA COVID vaccine booster shots

COVID-19 vaccination strategies that minimize R0 may offer greater protection to vulnerable age groups

A measles-vectored COVID-19 vaccine induces strong immunity in animal model

Psychiatric drug prevents some of the most serious complications of COVID-19, study finds

The role of T follicular helper cells in the humoral immune response to SARS-CoV-2

Pregnant women’s humoral response is dependent on SARS-CoV-2 strain

Impact of COVID-19 pandemic on women’s experience of pregnancy in UK

Novel tetravalent antibodies for the ultrapotent and broad neutralization of SARS-CoV-2 variants

Enhanced neutralizing antibody and T-cell responses by DNA-based vaccine encoding SARS-CoV-2 spike protein

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections

Increase in SARS-CoV-2 seroprevalence in Irish HCWs during third wave of pandemic

Household transmission of SARS-CoV-2 delta variant in England

What are the anti-COVID drugs currently in development?

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News